Matinas BioPharma Holdings, Inc. (MTNB) - Latest Market Data

Price & Market Data

Price: $0.704

Daily Change: +$0.0342 / 4.86%

Daily Range: $0.602 - $0.71

Market Cap: $4,510,599

Daily Volume: 42,891

Performance Metrics

1 Week: 12.28%

1 Month: 13.29%

3 Months: 1.22%

6 Months: -27.00%

1 Year: -18.31%

YTD: -1.64%

About Matinas BioPharma Holdings, Inc. (MTNB)

The definitive guide to Matinas BioPharma Holdings, Inc. (MTNB). Current price: 0.704, daily change: +$0.0342 / 4.86%. Market cap: 4,510,599. All performance metrics you need.

Company Details

Employees: 4

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company was incorporated in 2013 and is based in Bedminster, New Jersey.

Selected stocks

Uxin Limited (UXIN)

Holley Inc. (HLLY)

Filana Therapeutics, Inc. (FLNA)

Great Elm Group, Inc. (GEG)

Century Therapeutics, Inc. (IPSC)